We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Evotec SE

News List

Evotec SE Regains the Rights to All P2X3 Assets contractpharma
February 04, 2022
Bayer discontinues clinical development candidate eliapixant.
Evotec SE Expands UK Campus contractpharma
November 13, 2020
Evotec SE has expanded its existing campus based at Milton Park in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development center to be named Dorothy Crowfoot Hodgkin Campus.
Evotec and Ildong Enter Drug Development Collaboration contractpharma
April 02, 2020
Evotec SE has entered into a strategic collaboration with South Korean pharma firm, Ildong Pharmaceutical, to accelerate the development of several of Ildong's proprietary projects through access to Evotec's INDiGO platform.